Amdocs slides 3% as new price-target cut revives margin and outlook worries
Amdocs (DOX) fell 3.03% to $64.02 as investors continued repricing the stock after a fresh analyst price-target cut that highlighted valuation and a softer FY2026 profitability outlook. The decline also reflects lingering caution tied to the recent CEO transition and margin pressure from higher AI-related investment spending.
1. What’s moving DOX today
Amdocs shares were down 3.03% to $64.02 in U.S. trading as the market reacted to renewed concern about FY2026 profitability and valuation following a recent analyst price-target reduction that kept a positive rating but emphasized multiple compression risk and a tougher setup after the stock’s selloff. (uk.investing.com)
2. The backdrop: softer profitability signals and leadership change
The stock’s weakness comes after the company’s fiscal Q1 2026 update that beat on revenue and earnings but accompanied a tempered forward profitability profile, which helped trigger a sharp post-results drop and left the shares sensitive to any incremental negative framing. Investors have also been digesting a major leadership transition, with Shimie Hortig set to succeed Shuky Sheffer as CEO effective March 31, 2026, a change that can increase perceived execution risk during an AI-and-cloud product pivot. (stocktitan.net)
3. What investors are watching next
With the stock trading near recent lows, investors are focused on whether Amdocs can protect operating margins while funding AI initiatives and delivering on its FY2026 growth framework. Near-term catalysts include additional analyst actions, customer deal flow in telecom modernization programs, and any updates on capital returns, including the next quarterly dividend payment scheduled for April 24, 2026. (simplywall.st)